Wall Street Analysts Believe Day One Biopharmaceuticals (DAWN) Could Rally 303.46%: Here's is How to Trade

Day One Biopharmaceuticals, Inc. (DAWN) closed the last trading session at $6.94, gaining 7.8% over the past four weeks, but there could be plenty of upside left in the stock if short-term price targets set by Wall Street analysts are any guide. The mean price target of $28 indicates a 303.5% upside potential.The average comprises eight short-term price targets ranging from a low of $20.00 to a high of $36.00, with a standard deviation of $5.07. While the lowest estimate indicates an increase of 188.2% from ...